Watch Ticker

Ocular Therapeutix, Inc.

Go to Ocular Therapeutix, Inc. Website

$11.59

-0.76 (-6.19%)

Live

Previous Close

$12.35

Day Range

$10.58 - $11.96

Previous Day Range

$11.61 - $12.35

Market Cap

$1.9 billion USD

Day Vol.

2.1 million

Previous Day Vol.

1.8 million

Currency

USD

Primary Exchange

Nasdaq

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of e...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025

Ocular Therapeutix, a biopharmaceutical company, announced the closing of enrollment for its second registrational trial, SOL-R, evaluating AXPAXLI for the treatment of wet age-related macular degeneration. The trial is the largest retinal TKI trial to date, with plans to randomize at least 555 subjects.

Related tickers: OCUL.

Read Full Article

N/A - Ocular Therapeutix™ to Participate in Two Investor Conferences in April

Ocular Therapeutix, a biopharmaceutical company, announced its participation in two investor conferences in April 2025, where it will present its product candidate AXPAXLI for wet age-related macular degeneration and provide updates on its pipeline.

Related tickers: OCUL.

Read Full Article

Trending Tickers

Please sign in to view